Ilit Turgeman, MD

Dr. Ilit Turgeman is a thoracic medical oncologist and advanced clinical fellow at Dana-Farber Cancer Institute and Harvard Medical School. Her clinical and research work focuses on thoracic cancers and precision oncology, with a particular interest in understanding why cancers develop and behave differently from one person to another.

Her research in the Jänne Lab explores how aging, carcinogenic exposures, and genetic changes influence cancer development and response to treatment. By connecting observations from patient care with laboratory research, she hopes to better understand these differences and find new ways to improve treatment. Her broader work also examines how environmental factors affect cancer care. She serves on the International Association for the Study of Lung Cancer’s Global Policy and Partnerships Committee and holds a leadership role with Oncology Advocates United for Climate and Health (OUCH International).

Before joining Dana-Farber, Dr. Turgeman held clinical and research leadership roles in Israel. She led thoracic oncology at Emek Medical Center, where she co-founded a dedicated service for younger adults with cancer, and later helped develop thoracic oncology research and clinical trials at Carmel and Lin Medical Centers. Her work has included expanding access to clinical trials and cancer care in underserved regions.

Dr. Turgeman earned her medical degree from Hebrew University. She completed her medical oncology residency at Rambam Health Care Campus and pursued additional fellowship training in early-phase clinical trials at the Sarah Cannon Research Institute in the United Kingdom.

Dr. Turgeman reviews medical content for Mesothelioma.com, drawing on her experience in thoracic oncology and cancer research to help ensure information is medically accurate and current.